Philips advances AI-enabled streamlined workflow solutions in diagnostic X-ray at ECR 2021
March 04 2021 - 4:00AM
Philips advances AI-enabled streamlined workflow solutions in
diagnostic X-ray at ECR 2021
March 4, 2021
- New partnership with AI software provider Lunit to incorporate
its chest detection suite into Philips’ diagnostic X-ray suite
- Latest release of Philips Digital Radiography and Fluoroscopy
system (CombiDiagnost R90) receives FDA 510(k) clearance
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, today announced a
partnership to incorporate the Lunit INSIGHT CXR chest detection
suite into Philips’ diagnostic X-ray suite, during the European
Congress of Radiology (ECR) virtual event (March 3-7, 2021). The
partnership is one of the latest extensions of Philips’ AI-enabled
portfolio of solutions in precision diagnosis, which leverages the
company’s and third-party AI solutions to deliver optimized
workflows that empower providers, patients, and administrators to
turn data into actionable insights and drive the right care in the
right sequence at the right time. At ECR Philips also announced
that its Digital Radiography and Fluoroscopy system (CombiDiagnost
R90) has received FDA 510(k) clearance.
“For most patients, X-ray is the first diagnostic imaging step
on their path to a definitive diagnosis,” said Daan van Manen,
General Manager for Diagnostic X-ray at Philips. “Radiology
departments and their technologists are continually under pressure.
With simpler and more efficient workflows we can reduce variability
and staff workload, increase productivity, and enhance patient
experience. Our partnership with Lunit to incorporate their
diagnostic AI into our X-ray suite combines with a host of
intelligent and streamlined workflow features in the Philips
Radiography Unified User Interface (Eleva) across our digital
radiography systems, enabling a smooth and efficient,
patient-focused workflow. This is another step in contributing to
providing a path to precision diagnosis.”
Lunit INSIGHT CXR chest detection suite accurately detects 10 of
the most common findings in a chest X-ray, supports tuberculosis
screening, and has shown clinical efficiency for detecting
pneumonia, which can be an initial indication of COVID-19. By
prioritizing cases with abnormality scores and facilitating fast
triage of normal cases, the suite allows radiologists to focus on
reading the abnormal cases.
“By partnering with Philips, a major player in diagnostic X-ray,
our AI will be available to its significant global installed base,”
said Brandon Suh, CEO of Lunit. “We look forward to collaborating
together as we work towards our ambition to make data-driven
medicine the new standard of care. Lunit will continue to build
upon its current AI offering, making it better and better with
time, and will continue to deliver best-in-class AI.”
Through breakthrough innovation and partnerships, Philips
continues to integrate intelligence and automation into its
Precision Diagnosis portfolio. This includes its smart diagnostic
systems, integrated workflow solutions that can transform
departmental operations, advanced informatics that can provide
diagnostic confidence, and care pathway solutions that allow
doctors to tailor treatment to the individual patient.
Philips Digital Radiography and Fluoroscopy system
(CombiDiagnost R90) receives FDA 510(k) clearance At ECR 2021
Philips also announced that its Digital Radiography and Fluoroscopy
system (CombiDiagnost R90), a remote controlled fluoroscopy system
in combination with high-end digital radiography, has received
510(k) clearance from the U.S. Food and Drug Administration.
Designed to improve room utilization in a cost effective manner.
The versatile system combines a fully digital workflow, UNIQUE
image quality and excellent dose management for a wide range of
examinations from pediatric to bariatric imaging.
Philips is showcasing its latest advances in diagnostic X-ray
during the virtual ECR 2021. During the congress, Philips will host
a symposium with a panel of leading physicians: ‘Smart Workflows:
Improving imaging productivity and clinical confidence with AI’.
For more information on Philips’ new portfolio of diagnostic and
interventional solutions and AI-enabled applications to enhance
radiology workflows at ECR 2021, visit the Philips ECR site, and
follow @PhilipsLiveFrom for updates throughout the event.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916E-mail: mark.groves@philips.com
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail: kathy.oreilly@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Digital Radiography and Fluoroscopy system
(CombiDiagnost R90)
- Philips Digital Radiography and Fluoroscopy system
(CombiDiagnost R90) in use
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024